Smith & Nephew (SNN) Cash & Equivalents Growth (3y) (2012 - 2025)
Smith & Nephew (SNN) Cash & Equivalents Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 40.99% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 21.52% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -0.70% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 16.75% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 34.11% |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 28.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.75% |
| Dec 31, 2024 | -21.71% |
| Dec 31, 2023 | -44.45% |
| Dec 31, 2022 | 10.84% |
| Dec 31, 2021 | 57.05% |
| Dec 31, 2020 | 124.85% |
| Dec 31, 2019 | 89.11% |
| Dec 31, 2018 | 48.35% |
| Jun 30, 2018 | 4.00% |
| Dec 31, 2017 | 33.60% |
| Dec 31, 2016 | -34.78% |
| Dec 31, 2015 | -16.94% |
| Jun 30, 2015 | -26.43% |
| Dec 31, 2014 | -29.31% |
| Dec 31, 2013 | -12.85% |
| Dec 31, 2012 | 209.57% |
| Sep 29, 2012 | -98.73% |
| Jun 30, 2012 | -98.88% |
| Mar 31, 2012 | -99.99% |